Sunshine Biopharma Inc. Accounts Payable and Accrued Liabilities, Fair Value Disclosure
Sunshine Biopharma Inc. (SBFM) had Accounts Payable and Accrued Liabilities, Fair Value Disclosure of $336.00 thousand as of 2017-06-30, per its 10-Q filed 2017-08-11.
Discontinued › Notes
us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure · last filed 2017-08-11
- 2017-06-30: Accounts Payable and Accrued Liabilities, Fair Value Disclosure $336.00K.
- 2016-12-31: Accounts Payable and Accrued Liabilities, Fair Value Disclosure $0.00.
| Period end | Accounts Payable and Accrued Liabilities, Fair Value Disclosure |
|---|---|
| 2017-06-30 | $336.00K 10-Q · filed 2017-08-11 |
| 2016-12-31 | $0.00 10-Q · filed 2017-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |